Global and United States Duloxetine Active Pharmaceutical Ingredients (API) Market Report & Forecast 2023-2028

Report ID: 1822618 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Duloxetine Active Pharmaceutical Ingredients (API) Product Introduction
    1.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume for the Year 2017-2028
    1.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume for the Year 2017-2028
    1.4 Duloxetine Active Pharmaceutical Ingredients (API) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Duloxetine Active Pharmaceutical Ingredients (API) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Duloxetine Active Pharmaceutical Ingredients (API) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Duloxetine Active Pharmaceutical Ingredients (API) Market Dynamics
        1.5.1 Duloxetine Active Pharmaceutical Ingredients (API) Industry Trends
        1.5.2 Duloxetine Active Pharmaceutical Ingredients (API) Market Drivers
        1.5.3 Duloxetine Active Pharmaceutical Ingredients (API) Market Challenges
        1.5.4 Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Segment by Type
        2.1.1 Major Depression Drug
        2.1.2 Generalized Anxiety Disorder Drug
        2.1.3 Fibromyalgia Drugs
        2.1.4 Neuropathic Pain Medication
        2.1.5 Other
    2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Type
        2.2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Type
        2.3.1 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Segment by Application
        3.1.1 Pharmaceutical and Biotechnology Industries
        3.1.2 Hospital
        3.1.3 Other
    3.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Application
        3.2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Application
        3.3.1 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Duloxetine Active Pharmaceutical Ingredients (API) Competitor Landscape by Company
    4.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Company
        4.1.1 Top Global Duloxetine Active Pharmaceutical Ingredients (API) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Manufacturer (2017-2022)
        4.1.4 Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Manufacturer (2017-2022)
    4.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Concentration Ratio (CR)
        4.2.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Duloxetine Active Pharmaceutical Ingredients (API) in 2021
        4.2.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Product Type
        4.3.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Product Type
        4.3.3 Date of International Manufacturers Enter into Duloxetine Active Pharmaceutical Ingredients (API) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Company
        4.5.1 Top Duloxetine Active Pharmaceutical Ingredients (API) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Players (2020, 2021 & 2022)
5 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region
    5.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Region: 2017-2022
        5.2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size in Value by Region (2017-2028)
        5.3.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Region: 2017-2022
        5.3.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2017-2028
        6.1.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2017-2028
        6.3.2 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Duloxetine Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Teva Pharmaceutical Industries Ltd (Israel)
        7.1.1 Teva Pharmaceutical Industries Ltd (Israel) Corporation Information
        7.1.2 Teva Pharmaceutical Industries Ltd (Israel) Description and Business Overview
        7.1.3 Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.1.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Development
    7.2 Sun Pharmaceutical Industries Ltd (India)
        7.2.1 Sun Pharmaceutical Industries Ltd (India) Corporation Information
        7.2.2 Sun Pharmaceutical Industries Ltd (India) Description and Business Overview
        7.2.3 Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.2.5 Sun Pharmaceutical Industries Ltd (India) Recent Development
    7.3 Aurobindo Pharma (India)
        7.3.1 Aurobindo Pharma (India) Corporation Information
        7.3.2 Aurobindo Pharma (India) Description and Business Overview
        7.3.3 Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.3.5 Aurobindo Pharma (India) Recent Development
    7.4 Lupin (India)
        7.4.1 Lupin (India) Corporation Information
        7.4.2 Lupin (India) Description and Business Overview
        7.4.3 Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.4.5 Lupin (India) Recent Development
    7.5 Zydus Cadila (India)
        7.5.1 Zydus Cadila (India) Corporation Information
        7.5.2 Zydus Cadila (India) Description and Business Overview
        7.5.3 Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.5.5 Zydus Cadila (India) Recent Development
    7.6 Eli Lilly and Company (United States)
        7.6.1 Eli Lilly and Company (United States) Corporation Information
        7.6.2 Eli Lilly and Company (United States) Description and Business Overview
        7.6.3 Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.6.5 Eli Lilly and Company (United States) Recent Development
    7.7 Shodhana Laboratories (India)
        7.7.1 Shodhana Laboratories (India) Corporation Information
        7.7.2 Shodhana Laboratories (India) Description and Business Overview
        7.7.3 Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.7.5 Shodhana Laboratories (India) Recent Development
    7.8 Hetero (India)
        7.8.1 Hetero (India) Corporation Information
        7.8.2 Hetero (India) Description and Business Overview
        7.8.3 Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.8.5 Hetero (India) Recent Development
    7.9 Apotex (Canada)
        7.9.1 Apotex (Canada) Corporation Information
        7.9.2 Apotex (Canada) Description and Business Overview
        7.9.3 Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.9.5 Apotex (Canada) Recent Development
    7.10 Shionogi (US)
        7.10.1 Shionogi (US) Corporation Information
        7.10.2 Shionogi (US) Description and Business Overview
        7.10.3 Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.10.5 Shionogi (US) Recent Development
    7.11 Zhejiang Huahai Pharmaceutical (China)
        7.11.1 Zhejiang Huahai Pharmaceutical (China) Corporation Information
        7.11.2 Zhejiang Huahai Pharmaceutical (China) Description and Business Overview
        7.11.3 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Products Offered
        7.11.5 Zhejiang Huahai Pharmaceutical (China) Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Duloxetine Active Pharmaceutical Ingredients (API) Industry Chain Analysis
    8.2 Duloxetine Active Pharmaceutical Ingredients (API) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Duloxetine Active Pharmaceutical Ingredients (API) Distributors
    8.3 Duloxetine Active Pharmaceutical Ingredients (API) Production Mode & Process
    8.4 Duloxetine Active Pharmaceutical Ingredients (API) Sales and Marketing
        8.4.1 Duloxetine Active Pharmaceutical Ingredients (API) Sales Channels
        8.4.2 Duloxetine Active Pharmaceutical Ingredients (API) Distributors
    8.5 Duloxetine Active Pharmaceutical Ingredients (API) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Duloxetine Active Pharmaceutical Ingredients (API) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Duloxetine Active Pharmaceutical Ingredients (API) Market Trends
    Table 3. Duloxetine Active Pharmaceutical Ingredients (API) Market Drivers
    Table 4. Duloxetine Active Pharmaceutical Ingredients (API) Market Challenges
    Table 5. Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints
    Table 6. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Duloxetine Active Pharmaceutical Ingredients (API) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Duloxetine Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Duloxetine Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duloxetine Active Pharmaceutical Ingredients (API) as of 2021)
    Table 18. Top Players of Duloxetine Active Pharmaceutical Ingredients (API) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Product Type
    Table 20. Date of International Manufacturers Enter into Duloxetine Active Pharmaceutical Ingredients (API) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Duloxetine Active Pharmaceutical Ingredients (API) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Teva Pharmaceutical Industries Ltd (Israel) Corporation Information
    Table 43. Teva Pharmaceutical Industries Ltd (Israel) Description and Business Overview
    Table 44. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Product
    Table 46. Teva Pharmaceutical Industries Ltd (Israel) Recent Development
    Table 47. Sun Pharmaceutical Industries Ltd (India) Corporation Information
    Table 48. Sun Pharmaceutical Industries Ltd (India) Description and Business Overview
    Table 49. Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Sun Pharmaceutical Industries Ltd (India) Product
    Table 51. Sun Pharmaceutical Industries Ltd (India) Recent Development
    Table 52. Aurobindo Pharma (India) Corporation Information
    Table 53. Aurobindo Pharma (India) Description and Business Overview
    Table 54. Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Aurobindo Pharma (India) Product
    Table 56. Aurobindo Pharma (India) Recent Development
    Table 57. Lupin (India) Corporation Information
    Table 58. Lupin (India) Description and Business Overview
    Table 59. Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Lupin (India) Product
    Table 61. Lupin (India) Recent Development
    Table 62. Zydus Cadila (India) Corporation Information
    Table 63. Zydus Cadila (India) Description and Business Overview
    Table 64. Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Zydus Cadila (India) Product
    Table 66. Zydus Cadila (India) Recent Development
    Table 67. Eli Lilly and Company (United States) Corporation Information
    Table 68. Eli Lilly and Company (United States) Description and Business Overview
    Table 69. Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Eli Lilly and Company (United States) Product
    Table 71. Eli Lilly and Company (United States) Recent Development
    Table 72. Shodhana Laboratories (India) Corporation Information
    Table 73. Shodhana Laboratories (India) Description and Business Overview
    Table 74. Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Shodhana Laboratories (India) Product
    Table 76. Shodhana Laboratories (India) Recent Development
    Table 77. Hetero (India) Corporation Information
    Table 78. Hetero (India) Description and Business Overview
    Table 79. Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Hetero (India) Product
    Table 81. Hetero (India) Recent Development
    Table 82. Apotex (Canada) Corporation Information
    Table 83. Apotex (Canada) Description and Business Overview
    Table 84. Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Apotex (Canada) Product
    Table 86. Apotex (Canada) Recent Development
    Table 87. Shionogi (US) Corporation Information
    Table 88. Shionogi (US) Description and Business Overview
    Table 89. Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Shionogi (US) Product
    Table 91. Shionogi (US) Recent Development
    Table 92. Zhejiang Huahai Pharmaceutical (China) Corporation Information
    Table 93. Zhejiang Huahai Pharmaceutical (China) Description and Business Overview
    Table 94. Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Zhejiang Huahai Pharmaceutical (China) Product
    Table 96. Zhejiang Huahai Pharmaceutical (China) Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Duloxetine Active Pharmaceutical Ingredients (API) Customers List
    Table 100. Duloxetine Active Pharmaceutical Ingredients (API) Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Duloxetine Active Pharmaceutical Ingredients (API) Product Picture
    Figure 2. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales 2017-2028 (MT)
    Figure 5. United States Duloxetine Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Duloxetine Active Pharmaceutical Ingredients (API) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales 2017-2028 (MT)
    Figure 8. United States Duloxetine Active Pharmaceutical Ingredients (API) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Duloxetine Active Pharmaceutical Ingredients (API) Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Duloxetine Active Pharmaceutical Ingredients (API) Report Years Considered
    Figure 11. Product Picture of Major Depression Drug
    Figure 12. Product Picture of Generalized Anxiety Disorder Drug
    Figure 13. Product Picture of Fibromyalgia Drugs
    Figure 14. Product Picture of Neuropathic Pain Medication
    Figure 15. Product Picture of Other
    Figure 16. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Type in 2022 & 2028
    Figure 17. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028) & (MT)
    Figure 20. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2017-2028) & (USD/MT)
    Figure 22. United States Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Type in 2022 & 2028
    Figure 23. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028) & (MT)
    Figure 26. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2017-2028) & (USD/MT)
    Figure 28. Product Picture of Pharmaceutical and Biotechnology Industries
    Figure 29. Product Picture of Hospital
    Figure 30. Product Picture of Other
    Figure 31. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Application in 2022 & 2028
    Figure 32. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028) & (MT)
    Figure 35. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2017-2028) & (USD/MT)
    Figure 37. United States Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Application in 2022 & 2028
    Figure 38. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028) & (MT)
    Figure 41. United States Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2017-2028) & (USD/MT)
    Figure 43. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 44. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 48. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 55. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 67. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 72. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Duloxetine Active Pharmaceutical Ingredients (API) Value Chain
    Figure 77. Duloxetine Active Pharmaceutical Ingredients (API) Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva Pharmaceutical Industries Ltd (Israel)
Sun Pharmaceutical Industries Ltd (India)
Aurobindo Pharma (India)
Lupin (India)
Zydus Cadila (India)
Eli Lilly and Company (United States)
Shodhana Laboratories (India)
Hetero (India)
Apotex (Canada)
Shionogi (US)
Zhejiang Huahai Pharmaceutical (China)
Frequently Asked Questions
Duloxetine Active Pharmaceutical Ingredients (API) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Duloxetine Active Pharmaceutical Ingredients (API) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Duloxetine Active Pharmaceutical Ingredients (API) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Geo-Marketing

Geo-Marketing market is segmented by region (country), players, by Type and by Application. Playe ... Read More